91721-00-5

Basic information

• Product Name: Acetic acid, (2-acetyl-5-bromophenoxy)-, ethyl ester
• CAS NO: 91721-00-5
• Molecular Formula: C12H13BrO4
• Molecular Weight: 301.137
• Mol File: 91721-00-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Acetic acid, (2-acetyl-5-bromophenoxy)-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Acetic acid, (2-acetyl-5-bromophenoxy)-, ethyl ester(91721-00-5)
• EPA Substance Registry System: Acetic acid, (2-acetyl-5-bromophenoxy)-, ethyl ester(91721-00-5)

Safety Data

• Hazardous Substances Data: 91721-00-5(Hazardous Substances Data)

Upstream product

• 2398-37-0 3-methoxyphenyl bromide 
• 30186-18-6 4'-bromo-2'-hydroxyacetophenone 
• 105-36-2 ethyl bromoacetate 

Downstream Products

• 188714-73-0 5-[2-(2-Bromo-3-bromomethyl-benzofuran-6-yl)-phenyl]-1-trityl-1H-tetrazole 
• 188714-72-9 5-[2-(3-Bromomethyl-benzofuran-6-yl)-phenyl]-1-trityl-1H-tetrazole 
• 188714-71-8 5-[2-(3-Methyl-benzofuran-6-yl)-phenyl]-1-trityl-1H-tetrazole 
• 90772-69-3 2-(2-acetyl-5-bromophenoxy)acetic acid 

Relevant articles and documents

AGENT FOR CONTROLLING FUNCTION OF GPR34 RECEPTOR

The present invention provides a GPR receptor function regulator comprising the compound represented by the formula: [wherein ring A is an optionally substituted isocyclic or heterocyclic ring, P is a bond or spacer, ring D is an optionally substituted monocyclic aromatic ring which may be condensed with a 5-to 7-membered ring, V is a bond or the group represented by the formula -CR14=CR15 - or - N=CR16- (wherein R14, R15 and R16 each represents a hydrogen atom or optionally substituted hydrocarbon group), Q is a bond or spacer, and W is a carboxyl or a group biologically equivalent to a carboxyl] or its salt or a prodrug thereof

The conformation and activity relationship of benzofuran derivatives as angiotensin II receptor antagonists

We have synthesized various benzofuran derivatives to study the relationship between the conformation and the angiotensin II type I receptor antagonistic activity.